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In the late 18
th century, Erasmus Darwin, Charles Darwin’s grandfather, advocated evolu-
tionary theory as a mean to “unravel the theory of disease”. More than 200 years later,
although Darwinian medicine is regaining some ground after having been muzzled during
the second half of the 20
th century, genomics has largely outcompeted evolution and has
acquired a dictatorial success as a tool for studying disease etiology [1]. From an evolu-
tion-inspired perspective, we have gradually drifted into the habit of focusing primarily on
genomic data from sources such as genome-wide association studies (GWAS). As a result,
understanding the how and why of human diseases and pathobiology has largely become
a matter of crunching DNA sequences. Despite the popularity of GWAS, their reality
remains unchanged: most of the susceptibility loci they allow to identify explain only a
small fraction of the heritability of complex diseases [2]. A number of reasons for the so-
called “missing heritability” have been proposed [2], and our goal is not to review them all.
Here we primarily reiterate that there is more to discover than non-synonymous point
mutations and suggest that amid genetic deserts and genetic islands, there is also more to
explore than the coding regions of the genome. We then highlight the importance and the
necessity of designing efficient methods to mine beyond the exome.
The premise of GWAS is the “common disease-common variant” hypothesis, which
posits that common diseases are, at least partly, associated with DNA sequence variations
or polymorphisms present in more than 1-5% of the population. It turns out that most
allele frequencies battle to reach the 5% detection threshold of commercial genotyping
arrays and the “common disease-rare variant” hypothesis is gradually taking precedence
over its counterpart [2]. Hence, aiming for the rare variants using whole genome sequen-
cing for example is one first step into the right direction [3]. A further step is to deliber-
ately include synonymous polymorphisms among the genetic variants considered in
association studies. Although largely disregarded, synonymous polymorphisms are about
twice as numerous as non-synonymous ones [4] and are often found responsible for
altered protein structure, function and expression level [5]. Accordingly, a considerable list
of disease-associated synonymous polymorphisms is already available [5] and there are
more to be found. Besides single nucleotide polymorphisms (SNPs), variation can also be
structural: multi-kilobase genomic regions can be inserted or deleted (copy number varia-
tion, CNV), or they can be moved (copy neutral variation), within (inversion) or between
(translocation) chromosomes [6,7]. Structural variants have already been shown to contri-
bute to disease phenotypes [8,9], but with the help of high resolution GWAS purposely
designed to detect them, there are undoubtedly more discoveries ahead [6,7].
Variants can adopt different forms but they can also occur in different locations
throughout the genome. When given the choice between (quasi) random SNPs and
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reproduction in any medium, provided the original work is properly cited.SNPs located in coding regions (gene-centric approach), choosing the latter is the safer
bet [10]. However, the fact that more than 80% of the risk-associated variants identified
so far fall outside of the coding regions suggests that there is a third option, namely
the non-coding regions of the genome, including intergenic regions, introns and 3’ and
5’ untranscribed regions [11]. Non-coding regions harbor plenty of functional DNA,
composed essentially of regulatory elements such as enhancers, promoters, insulators
and silencer, and of non-coding functional RNA such as micro-RNA (miRNA). As the
non-coding regions of the genome have gradually been revealing their secretes, evi-
dence for their etiological importance has accumulated. Accordingly, genetic variation
at regulatory elements [12-15] and at miRNA [16-18] has been found to play an
important role in various diseases. Both better SNP coverage and whole genome
sequencing will allow for a more methodological exploration of the non-coding regions
of the genome.
There is more to the genome than we may have believed. Yet novel discoveries heav-
ily rely on the availability of adequate and powerful analytical tools to exploit rich and
complex data. In particular, progress in our understanding of the genetic architecture
of common diseases requires efficient methods for merging different types of data and
exploiting them simultaneously. Recent literature provides promising ideas on how to
combine expert knowledge and crude genotyping data. Cowper et al. [14] for example
suggest the use of genome-wide regulatory networks as a framework to incorporate
biological knowledge to the analysis and interpretation of genotyping data, including
data collected in the non-coding regions of the genome. This fits into a broader sys-
tems genetics approach to human disease [19]. Data are accumulating at a faster rate
than methodological tools do. We suggest that there is room and urgent need for
more ideas on how to analyze and integrate the different sources of information that
we extract from both popular and remote regions of the genome. The last five years
has focused on the task of manipulating large genomic data sets. Now is the time to
integrate and synthesize these disparate sources of genomic information.
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